The agency said it would approve new versions of the vaccine only for adults 65 years of age and older as well as for people with one or more risk factors for severe COVID-19 outcomes. These risk ...

Older adults can continue getting covid boosters, but not everyone who wants them can. You’re reading The Checkup With Dr.

On May 15, 2025, the U.S. Food and Drug Administration (FDA) announced the launch of “a stronger, more systematic review process for food chemicals already on the market — especially those that ...

Discover industry-tested approaches to strengthen quality systems and navigate regulatory scrutiny in this comprehensive ...

Johnson & Johnson has won the support of an FDA expert panel in its bid to make Darzalex the first treatment for an early ...

Latest developments expand Predictive’s AI-driven drug discovery platform to include biomarker discovery and drug repurposing ...

Atai Capital experienced a decline of 1.2% in the first quarter of 2025 net of all fees. Click here to read the full letter.

The NSW pill testing trial was launched after an urgent warning about a deadly synthetic drug 100 times more powerful than ...

Incyte Corp.’s Zynyz (retifanlimab-dlwr) has received another U.S. FDA approval and put some distance between it and a 2021 ...